Forced Expiratory Volume
"Forced Expiratory Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
Descriptor ID |
D005541
|
MeSH Number(s) |
E01.370.386.700.660.230 G09.772.650.430
|
Concept/Terms |
Forced Expiratory Volume- Forced Expiratory Volume
- Expiratory Volume, Forced
- Expiratory Volumes, Forced
- Forced Expiratory Volumes
- Volume, Forced Expiratory
- Volumes, Forced Expiratory
- FEVt
- Vital Capacity, Timed
- Forced Vital Capacity, Timed
- Timed Vital Capacity
- Capacities, Timed Vital
- Capacity, Timed Vital
- Timed Vital Capacities
- Vital Capacities, Timed
|
Below are MeSH descriptors whose meaning is more general than "Forced Expiratory Volume".
Below are MeSH descriptors whose meaning is more specific than "Forced Expiratory Volume".
This graph shows the total number of publications written about "Forced Expiratory Volume" by people in this website by year, and whether "Forced Expiratory Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 | 2011 | 0 | 1 | 1 | 2013 | 0 | 1 | 1 | 2015 | 0 | 2 | 2 | 2018 | 0 | 2 | 2 | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Forced Expiratory Volume" by people in Profiles.
-
Nichols DP, Singh PK, Baines A, Caverly LJ, Chmiel JF, GIbson RL, Lascano J, Morgan SJ, Retsch-Bogart G, Saiman L, Sadeghi H, Billings JL, Heltshe SL, Kirby S, Kong A, Nick JA, Mayer-Hamblett N. Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax. 2022 06; 77(6):581-588.
-
Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018 10 25; 379(17):1599-1611.
-
Tam A, Chen S, Schauer E, Grafe I, Bandi V, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Byers PH, Sandhaus RA, Durigova M, Glorieux FH, Rauch F, Reid Sutton V, Lee B, Rush ET, Nagamani SCS. A multicenter study to evaluate pulmonary function in osteogenesis imperfecta. Clin Genet. 2018 12; 94(6):502-511.
-
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 2015 07 16; 373(3):220-31.
-
McPhail GL, Ehsan Z, Howells SA, Boesch RP, Fenchel MC, Szczesniak R, Jain V, Agabegi S, Sturm P, Wall E, Redding GJ. Obstructive lung disease in children with idiopathic scoliosis. J Pediatr. 2015 Apr; 166(4):1018-21.
-
Ehsan Z, Montgomery GS, Tiller C, Kisling J, Chang DV, Tepper RS. An infant with pulmonary interstitial glycogenosis: clinical improvement is associated with improvement in the pulmonary diffusion capacity. Pediatr Pulmonol. 2014 Mar; 49(3):E17-20.
-
Labuda M, Laberge S, Bri?re J, B?rub? D, Beaulieu P, Pastinen T, Krajinovic M. Phosphodiesterase type 4D gene polymorphism: association with the response to short-acting bronchodilators in paediatric asthma patients. Mediators Inflamm. 2011; 2011:301695.
-
Sharma S, Tantisira K, Carey V, Murphy AJ, Lasky-Su J, Celed?n JC, Lazarus R, Klanderman B, Rogers A, Soto-Quir?s M, Avila L, Mariani T, Gaedigk R, Leeder S, Torday J, Warburton D, Raby B, Weiss ST. A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am J Respir Crit Care Med. 2010 Feb 15; 181(4):328-36.
-
Wiens L, Sabath R, Ewing L, Gowdamarajan R, Portnoy J, Scagliotti D. Chest pain in otherwise healthy children and adolescents is frequently caused by exercise-induced asthma. Pediatrics. 1992 Sep; 90(3):350-3.
-
Guss S, Portnoy J. Methotrexate treatment of severe asthma in children. Pediatrics. 1992 Apr; 89(4 Pt 1):635-9.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|